The American Journal of Managed Care > January 2011

The American Journal of Managed Care - January 2011

January 24, 2011 – Harris S. Silver, MD; Christopher M. Blanchette, PhD; Shital Kamble, PhD; Hans Petersen, MS; Matthew A. Letter, BS; David Meddis, PhD; and Benjamin Gutierrez, PhD

Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.

January 25, 2011 – Harry L. Leider, MD, MBA; Jatinder Dhaliwal, MBA; Elizabeth J. Davis, PhD; Mahesh Kulakodlu, MS; and Ami R. Buikema, MPH

Healthcare costs are elevated for patients on chronic opioid therapy; nonadherence to the opioid regimen, based on urine drug monitoring results, further increases costs.

January 25, 2011 – William Boulding, PhD; Seth W. Glickman, MD, MBA; Matthew P. Manary, MSE; Kevin A. Schulman, MD; and Richard Staelin, PhD

Higher overall patient satisfaction with inpatient care and discharge planning is associated with lower 30-day readmission rates after adjusting for clinical quality.

January 26, 2011 – Wendy L. Wright, MS; Joan E. Romboli, MSN; Margaret A. DiTulio, MS, MBA; Jenifer Wogen, MS; and Daniel A. Belletti, MA

This cross-sectional retrospective study found comparable blood pressure control rates among patients with hypertension receiving primary care from a nurse practitioner versus a physician.

January 28, 2011 – Richard M. Hoffman, MD, MPH; Susan R. Steel, RN, MSN; Ellen F. T. Yee, MD; Larry Massie, MD; Ronald M. Schrader, PhD; Maurice L. Moffett, PhD; and Glen H. Murata, MD

Using an electronic health record to identify and implement colorectal cancer screening in a population of eligible patients achieved higher uptake than a visit-based approach.

January 29, 2011 – Mary E. Charlton, PhD; Barcey T. Levy, PhD, MD; Robin R. High, MBA, MA; John E. Schneider, PhD; and John M. Brooks, PhD

The health savings account-eligible design may decrease costs and utilization, but it also may decrease use of preventive services.

January 29, 2011 – Sally Elizabeth Turbyville, MA, MS; Meredith B. Rosenthal, PhD; L. Gregory Pawlson, MD; and Sarah Hudson Scholle, DrPH

There is a critical need for comparative information about plan resource use to support value-based purchasing efforts.

January 14, 2011 – Bruce Y. Lee, MD, MBA; Julie H. Y. Tai, MD; Rachel R. Bailey, MPH; Sarah M. McGlone, MPH; Ann E. Wiringa, MPH; Shanta M. Zimmer, MD; Kenneth J. Smith, MD, MS; and Richard K. Zimmerman, MD, MPH

The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.

January 14, 2011 – Brenda R. Motheral, PhD

To generate cost savings, plan sponsors should implement transitional care programs and disease management programs that consider risk, actionability, treatment and program effectiveness, and costs.

January 14, 2011 – Katy Backes Kozhimannil, PhD, MPA; Haiden A. Huskamp, PhD; Amy Johnson Graves, MPH; Stephen B. Soumerai, ScD; Dennis Ross-Degnan, ScD; and J. Frank Wharam, MB, BCh, MPH

High-deductible benefit design was associated with increased out-of-pocket costs for maternity care, but had no adverse impacts on receipt of recommended prenatal and postpartum care.

March 10, 2011 – Katy Backes Kozhimannil, PhD, MPA; Haiden A. Huskamp, PhD; Amy Johnson Graves, MPH; Stephen B. Soumerai, ScD; Dennis Ross-Degnan, ScD; and J. Frank Wharam, MB, BCh, MPH
High-deductible benefit design was associated with increased out-of-pocket costs for maternity care, but had no adverse impacts on receipt of recommended prenatal and postpartum care.
March 10, 2011 – Bruce Y. Lee, MD, MBA; Julie H. Y. Tai, MD; Rachel R. Bailey, MPH; Sarah M. McGlone, MPH; Ann E. Wiringa, MPH; Shanta M. Zimmer, MD; Kenneth J. Smith, MD, MS; and Richard K. Zimmerman, MD, MPH
The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.
March 10, 2011 – Brenda R. Motheral, PhD
To generate cost savings, plan sponsors should implement transitional care programs and disease management programs that consider risk, actionability, treatment and program effectiveness, and costs.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!